{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:53:12Z","timestamp":1791316392926,"version":"4.3.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11060-010-0342-2","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T08:50:01Z","timestamp":1283244601000},"page":"379-391","source":"Crossref","is-referenced-by-count":327,"title":["Pathological classification and molecular genetics of meningiomas"],"prefix":"10.1007","volume":"99","author":[{"given":"Christian","family":"Mawrin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"342_CR1","unstructured":"Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States, 1997\u20132001. In: CBTRUS (ed). Hinsdale, IL"},{"key":"342_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0090-3019(87)90005-X","volume":"27","author":"S Nakasu","year":"1987","unstructured":"Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas in autopsy study. Surg Neurol 27:319\u2013322","journal-title":"Surg Neurol"},{"key":"342_CR3","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJMoa070972","volume":"357","author":"MW Vernooij","year":"2007","unstructured":"Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ, Breteler MM, van der Lugt A (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821\u20131828","journal-title":"N Engl J Med"},{"key":"342_CR4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1750-3639.2005.tb00505.x","volume":"15","author":"A Perry","year":"2005","unstructured":"Perry A, Lusis EA, Gutmann DH (2005) Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases. Brain Pathol 15:109\u2013115","journal-title":"Brain Pathol"},{"key":"342_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3171\/jns.1986.64.1.0058","volume":"64","author":"B Borovich","year":"1986","unstructured":"Borovich B, Doron Y (1986) Recurrence of intracranial meningiomas: the role played by regional multicentricity. J Neurosurg 64:58\u201363","journal-title":"J Neurosurg"},{"key":"342_CR6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3171\/jns.1997.86.5.0853","volume":"86","author":"AP Stangl","year":"1997","unstructured":"Stangl AP, Wellenreuther R, Lenartz D, Kraus JA, Menon AG, Schramm J, Wiestler OD, von Deimling A (1997) Clonality of multiple meningiomas. J Neurosurg 86:853\u2013858","journal-title":"J Neurosurg"},{"key":"342_CR7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455\u20131465","journal-title":"Am J Surg Pathol"},{"key":"342_CR8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","volume":"95","author":"A Durand","year":"2009","unstructured":"Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamarides M, Menei P, Deruty R, Moreau JJ, Fevre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367\u2013375","journal-title":"J Neurooncol"},{"key":"342_CR9","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) \u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046\u20132056","journal-title":"Cancer"},{"key":"342_CR10","doi-asserted-by":"crossref","unstructured":"Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT Jr, Barker FG II (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56\u201360; discussion 60","DOI":"10.1227\/01.NEU.0000330399.55586.63"},{"key":"342_CR11","first-page":"176","volume-title":"Pathology and genetics of tumours of the nervous system","author":"DN Louis","year":"2000","unstructured":"Louis DN, Scheithauer BW, Budka H, Von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC press, Lyon, pp 176\u2013184"},{"key":"342_CR12","doi-asserted-by":"crossref","unstructured":"Smith SJ, Boddu S, Macarthur DC (2007) Atypical meningiomas: WHO moved the goalposts? Br J Neurosurg 21:588\u2013592","DOI":"10.1080\/02688690701684246"},{"key":"342_CR13","first-page":"164","volume-title":"WHO classification of tumours of the central nervous system","author":"A Perry","year":"2007","unstructured":"Perry A, Louis DN, Scheithauer BW, Budka H, Von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 164\u2013172"},{"key":"342_CR14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00005072-199509000-00012","volume":"54","author":"S Hirota","year":"1995","unstructured":"Hirota S, Nakajima Y, Yoshimine T, Kohri K, Nomura S, Taneda M, Hayakawa T, Kitamura Y (1995) Expression of bone-related protein messenger RNA in human meningiomas: possible involvement of osteopontin in development of psammoma bodies. J Neuropathol Exp Neurol 54:698\u2013703","journal-title":"J Neuropathol Exp Neurol"},{"key":"342_CR15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3171\/jns.1991.74.1.0129","volume":"74","author":"DN Louis","year":"1991","unstructured":"Louis DN, Hamilton AJ, Sobel RA, Ojemann RG (1991) Pseudopsammomatous meningioma with elevated serum carcinoembryonic antigen: a true secretory meningioma. Case report. J Neurosurg 74:129\u2013132","journal-title":"J Neurosurg"},{"key":"342_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1097-0142(19880715)62:2<391::AID-CNCR2820620226>3.0.CO;2-7","volume":"62","author":"JJ Kepes","year":"1988","unstructured":"Kepes JJ, Chen WY, Connors MH, Vogel FS (1988) \u201cChordoid\u201d meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases. Cancer 62:391\u2013406","journal-title":"Cancer"},{"key":"342_CR17","author":"J-W Lin","year":"2010","unstructured":"Lin J-W, Ho J-T, Lin Y-J, Wu Y-T (2010) Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution. J Neurooncol. doi: 10.1007\/s11060-010-0211-z","journal-title":"J Neurooncol"},{"key":"342_CR18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00000478-200007000-00001","volume":"24","author":"ME Couce","year":"2000","unstructured":"Couce ME, Aker FV, Scheithauer BW (2000) Chordoid meningioma: a clinicopathologic study of 42 cases. Am J Surg Pathol 24:899\u2013905","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"342_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-009-0097-9","volume":"99","author":"ML Tena-Suck","year":"2010","unstructured":"Tena-Suck ML, Collado-Ortiz MA, Salinas-Lara C, Garcia-Lopez R, Gelista N, Rembao-Bojorquez D (2010) Chordoid meningioma: a report of ten cases. J Neurooncol 99(1):41\u201348","journal-title":"J Neurooncol"},{"key":"342_CR20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/00000478-199812000-00005","volume":"22","author":"A Perry","year":"1998","unstructured":"Perry A, Scheithauer BW, Stafford SL, Abell-Aleff PC, Meyer FB (1998) \u201cRhabdoid\u201d meningioma: an aggressive variant. Am J Surg Pathol 22:1482\u20131490","journal-title":"Am J Surg Pathol"},{"key":"342_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1750-3639.2004.tb00092.x","volume":"14","author":"C Mawrin","year":"2004","unstructured":"Mawrin C, Hahne R, Scherlach C, Kirches E, Dietzmann K (2004) June 2004: a male in his late 60s with recurrent extracerebral tumor. Brain Pathol 14:457\u2013459","journal-title":"Brain Pathol"},{"key":"342_CR22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/07357900601062339","volume":"24","author":"SM Grunberg","year":"2006","unstructured":"Grunberg SM, Weiss MH, Russell CA, Spitz IM, Ahmadi J, Sadun A, Sitruk-Ware R (2006) Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest 24:727\u2013733","journal-title":"Cancer Invest"},{"key":"342_CR23","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R","volume":"82","author":"A Perry","year":"1998","unstructured":"Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262\u20132269","journal-title":"Cancer"},{"key":"342_CR24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000478-200104000-00006","volume":"25","author":"S Nakasu","year":"2001","unstructured":"Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M (2001) Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25:472\u2013478","journal-title":"Am J Surg Pathol"},{"key":"342_CR25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0046-8177(98)90224-6","volume":"29","author":"E Karamitopoulou","year":"1998","unstructured":"Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140\u2013145","journal-title":"Hum Pathol"},{"key":"342_CR26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10014-009-0251-2","volume":"26","author":"S Nakasu","year":"2009","unstructured":"Nakasu S, Fukami T, Jito J, Nozaki K (2009) Recurrence and regrowth of benign meningiomas. Brain Tumor Pathol 26:69\u201372","journal-title":"Brain Tumor Pathol"},{"key":"342_CR27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0029-1243244","volume":"52","author":"K Nakaya","year":"2009","unstructured":"Nakaya K, Chernov M, Kasuya H, Izawa M, Hayashi M, Kato K, Kubo O, Muragaki Y, Iseki H, Hori T, Okada Y, Takakura K (2009) Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index. Minim Invasive Neurosurg 52:216\u2013221","journal-title":"Minim Invasive Neurosurg"},{"key":"342_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.humpath.2009.06.020","volume":"41","author":"V Karja","year":"2010","unstructured":"Karja V, Sandell PJ, Kauppinen T, Alafuzoff I (2010) Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Hum Pathol 41:199\u2013207","journal-title":"Hum Pathol"},{"key":"342_CR29","first-page":"190","volume":"20","author":"SH Torp","year":"2001","unstructured":"Torp SH, Lindboe CF, Granli US, Moen TM, Nordtomme T (2001) Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas. Clin Neuropathol 20:190\u2013195","journal-title":"Clin Neuropathol"},{"key":"342_CR30","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.pas.0000141389.06925.d5","volume":"28","author":"T Ribalta","year":"2004","unstructured":"Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN (2004) The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria. Am J Surg Pathol 28:1532\u20131536","journal-title":"Am J Surg Pathol"},{"key":"342_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10014-009-0249-9","volume":"26","author":"S Fukushima","year":"2009","unstructured":"Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M (2009) Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases. Brain Tumor Pathol 26:51\u201357","journal-title":"Brain Tumor Pathol"},{"key":"342_CR32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/1097-0142(20010801)92:3<701::AID-CNCR1373>3.0.CO;2-7","volume":"92","author":"A Perry","year":"2001","unstructured":"Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT (2001) Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer 92:701\u2013711","journal-title":"Cancer"},{"key":"342_CR33","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/j.1349-7006.2009.01308.x","volume":"100","author":"H Ohgaki","year":"2009","unstructured":"Ohgaki H, Kleihues P (2009) Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100:2235\u20132241","journal-title":"Cancer Sci"},{"key":"342_CR34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","volume":"26","author":"J Jaaskelainen","year":"1986","unstructured":"Jaaskelainen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461\u2013469","journal-title":"Surg Neurol"},{"key":"342_CR35","doi-asserted-by":"crossref","unstructured":"Kheradmand A, Smith T: Dural metastatic adenocarcinoma mimicking meningioma. Neurology 74:1396","DOI":"10.1212\/WNL.0b013e3181dad61a"},{"key":"342_CR36","unstructured":"Richiello A, Sparano L, Del Basso De Caro ML, Russo G (2003) Dural metastasis mimicking falx meningioma. Case report. J Neurosurg Sci 47:167\u2013171; discussion 171"},{"key":"342_CR37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00428-010-0888-6","volume":"456","author":"A Ambrosini-Spaltro","year":"2010","unstructured":"Ambrosini-Spaltro A, Eusebi V (2010) Meningeal hemangiopericytomas and hemangiopericytoma\/solitary fibrous tumors of extracranial soft tissues: a comparison. Virchows Arch 456:343\u2013354","journal-title":"Virchows Arch"},{"key":"342_CR38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/00313020903071439","volume":"41","author":"A Mekni","year":"2009","unstructured":"Mekni A, Kourda J, Hammouda KB, Tangour M, Kchir N, Zitouna M, Haouet S (2009) Solitary fibrous tumour of the central nervous system: pathological study of eight cases and review of the literature. Pathology 41:649\u2013654","journal-title":"Pathology"},{"key":"342_CR39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5414\/NPP28453","volume":"28","author":"T Psaras","year":"2009","unstructured":"Psaras T, Pantazis G, Steger V, Meyermann R, Honegger J, Beschorner R (2009) Benign meningioma developing late lung metastases: case report and review of the literature. Clin Neuropathol 28:453\u2013459","journal-title":"Clin Neuropathol"},{"key":"342_CR40","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1200\/JCO.2008.17.7337","volume":"26","author":"EM Azene","year":"2008","unstructured":"Azene EM, Gai QW, Tabar SP, Morrison AL, Meisenberg B (2008) Metastasis of a histologically benign\u2014appearing meningioma to the iliac bone. J Clin Oncol 26:4688\u20134690","journal-title":"J Clin Oncol"},{"key":"342_CR41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jocn.2009.05.025","volume":"17","author":"A Mahore","year":"2010","unstructured":"Mahore A, Chagla A, Goel A (2010) Seeding metastases of a benign intraventricular meningioma along the surgical track. J Clin Neurosci 17:253\u2013255","journal-title":"J Clin Neurosci"},{"key":"342_CR42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3171\/jns.1994.81.3.0466","volume":"81","author":"S Albrecht","year":"1994","unstructured":"Albrecht S, Goodman JC, Rajagopolan S, Levy M, Cech DA, Cooley LD (1994) Malignant meningioma in Gorlin\u2019s syndrome: cytogenetic and p53 gene analysis. Case report. J Neurosurg 81:466\u2013471","journal-title":"J Neurosurg"},{"key":"342_CR43","first-page":"327","volume":"14","author":"CF Lindboe","year":"1995","unstructured":"Lindboe CF, Helseth E, Myhr G (1995) Lhermitte-Duclos disease and giant meningioma as manifestations of Cowden\u2019s disease. Clin Neuropathol 14:327\u2013330","journal-title":"Clin Neuropathol"},{"key":"342_CR44","first-page":"983","volume":"36","author":"J Moura De","year":"2010","unstructured":"De Moura J, Kavalec FL, Doghman M, Rosati R, Custodio G, Lalli E, Cavallari GM, Santa Maria J, Figueiredo BC (2010) Heterozygous TP53stop146\/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage. Int J Oncol 36:983\u2013990","journal-title":"Int J Oncol"},{"key":"342_CR45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-1-38","volume":"1","author":"F Marini","year":"2006","unstructured":"Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML (2006) Multiple endocrine neoplasia type 1. Orphanet J Rare Dis 1:38","journal-title":"Orphanet J Rare Dis"},{"key":"342_CR46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","volume":"6","author":"MH Ruttledge","year":"1994","unstructured":"Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP et al (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180\u2013184","journal-title":"Nat Genet"},{"key":"342_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gcc.20141","volume":"42","author":"J Lomas","year":"2005","unstructured":"Lomas J, Bello MJ, Arjona D, Alonso ME, Martinez-Glez V, Lopez-Marin I, Aminoso C, de Campos JM, Isla A, Vaquero J, Rey JA (2005) Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromosomes Cancer 42:314\u2013319","journal-title":"Genes Chromosomes Cancer"},{"key":"342_CR48","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm0898-915","volume":"4","author":"Y Kimura","year":"1998","unstructured":"Kimura Y, Koga H, Araki N, Mugita N, Fujita N, Takeshima H, Nishi T, Yamashima T, Saido TC, Yamasaki T, Moritake K, Saya H, Nakao M (1998) The involvement of calpain-dependent proteolysis of the tumor suppressor NF2 (merlin) in schwannomas and meningiomas. Nat Med 4:915\u2013922","journal-title":"Nat Med"},{"key":"342_CR49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2164-8-16","volume":"8","author":"CM Hansson","year":"2007","unstructured":"Hansson CM, Buckley PG, Grigelioniene G, Piotrowski A, Hellstrom AR, Mantripragada K, Jarbo C, Mathiesen T, Dumanski JP (2007) Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMC Genomics 8:16","journal-title":"BMC Genomics"},{"key":"342_CR50","first-page":"827","volume":"146","author":"R Wellenreuther","year":"1995","unstructured":"Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827\u2013832","journal-title":"Am J Pathol"},{"key":"342_CR51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1750-3639.2006.tb00557.x","volume":"16","author":"C Hartmann","year":"2006","unstructured":"Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A (2006) NF2 mutations in secretory and other rare variants of meningiomas. Brain Pathol 16:15\u201319","journal-title":"Brain Pathol"},{"key":"342_CR52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/path.909","volume":"194","author":"J Kros","year":"2001","unstructured":"Kros J, de Greve K, van Tilborg A, Hop W, Pieterman H, Avezaat C, Lekanne Dit Deprez R, Zwarthoff E (2001) NF2 status of meningiomas is associated with tumour localization and histology. J Pathol 194:367\u2013372","journal-title":"J Pathol"},{"key":"342_CR53","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/hmg\/3.8.1393","volume":"3","author":"M Peyrard","year":"1994","unstructured":"Peyrard M, Fransson I, Xie YG, Han FY, Ruttledge MH, Swahn S, Collins JE, Dunham I, Collins VP, Dumanski JP (1994) Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 3:1393\u20131399","journal-title":"Hum Mol Genet"},{"key":"342_CR54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cancergencyto.2008.01.020","volume":"183","author":"K Wozniak","year":"2008","unstructured":"Wozniak K, Piaskowski S, Gresner SM, Golanska E, Bieniek E, Bigoszewska K, Sikorska B, Szybka M, Kulczycka-Wojdala D, Zakrzewska M, Zawlik I, Papierz W, Stawski R, Jaskolski DJ, Och W, Sieruta M, Liberski PP, Rieske P (2008) BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Cancer Genet Cytogenet 183:14\u201320","journal-title":"Cancer Genet Cytogenet"},{"key":"342_CR55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","volume":"20","author":"D Barski","year":"2010","unstructured":"Barski D, Wolter M, Reifenberger G, Riemenschneider MJ (2010) Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol 20:623\u2013631","journal-title":"Brain Pathol"},{"key":"342_CR56","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/hmg\/9.10.1495","volume":"9","author":"DH Gutmann","year":"2000","unstructured":"Gutmann DH, Donahoe J, Perry A, Lemke N, Gorse K, Kittiniyom K, Rempel SA, Gutierrez JA, Newsham IF (2000) Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet 9:1495\u20131500","journal-title":"Hum Mol Genet"},{"key":"342_CR57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cancergencyto.2005.04.003","volume":"162","author":"F Nunes","year":"2005","unstructured":"Nunes F, Shen Y, Niida Y, Beauchamp R, Stemmer-Rachamimov AO, Ramesh V, Gusella J, MacCollin M (2005) Inactivation patterns of NF2 and DAL-1\/4.1B (EPB41L3) in sporadic meningioma. Cancer Genet Cytogenet 162:135\u2013139","journal-title":"Cancer Genet Cytogenet"},{"key":"342_CR58","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.1128\/MCB.25.22.10052-10059.2005","volume":"25","author":"C Yi","year":"2005","unstructured":"Yi C, McCarty JH, Troutman SA, Eckman MS, Bronson RT, Kissil JL (2005) Loss of the putative tumor suppressor band 4.1B\/Dal1 gene is dispensable for normal development and does not predispose to cancer. Mol Cell Biol 25:10052\u201310059","journal-title":"Mol Cell Biol"},{"key":"342_CR59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.10840","volume":"103","author":"B Heinrich","year":"2003","unstructured":"Heinrich B, Hartmann C, Stemmer-Rachamimov AO, Louis DN, MacCollin M (2003) Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms. Int J Cancer 103:483\u2013488","journal-title":"Int J Cancer"},{"key":"342_CR60","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/sj.onc.1207445","volume":"23","author":"VA Robb","year":"2004","unstructured":"Robb VA, Li W, Gutmann DH (2004) Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression. Oncogene 23:3589\u20133596","journal-title":"Oncogene"},{"key":"342_CR61","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2010.04.009","volume":"1336","author":"Y Liu","year":"2010","unstructured":"Liu Y, Tian RF, Li YM, Liu WP, Cao L, Yang XL, Cao WD, Zhang X (2010) The expression of seven 14-3-3 isoforms in human meningioma. Brain Res 1336:98\u2013102","journal-title":"Brain Res"},{"key":"342_CR62","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/jnen\/63.10.1015","volume":"63","author":"EI Surace","year":"2004","unstructured":"Surace EI, Lusis E, Murakami Y, Scheithauer BW, Perry A, Gutmann DH (2004) Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival. J Neuropathol Exp Neurol 63:1015\u20131027","journal-title":"J Neuropathol Exp Neurol"},{"key":"342_CR63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/path.1909","volume":"208","author":"AA Tilborg van","year":"2006","unstructured":"van Tilborg AA, Morolli B, Giphart-Gassler M, de Vries A, van Geenen DA, Lurkin I, Kros JM, Zwarthoff EC (2006) Lack of genetic and epigenetic changes in meningiomas without NF2 loss. J Pathol 208:564\u2013573","journal-title":"J Pathol"},{"key":"342_CR64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-6-64","volume":"6","author":"LH Carvalho","year":"2007","unstructured":"Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A (2007) Molecular signatures define two main classes of meningiomas. Mol Cancer 6:64","journal-title":"Mol Cancer"},{"key":"342_CR65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","volume":"101","author":"O Al-Mefty","year":"2004","unstructured":"Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210\u2013218","journal-title":"J Neurosurg"},{"key":"342_CR66","doi-asserted-by":"crossref","first-page":"14719","DOI":"10.1073\/pnas.94.26.14719","volume":"94","author":"RG Weber","year":"1997","unstructured":"Weber RG, Bostrom J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P (1997) Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719\u201314724","journal-title":"Proc Natl Acad Sci USA"},{"key":"342_CR67","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/NEN.0b013e3181ba3952","volume":"68","author":"D Gabeau-Lacet","year":"2009","unstructured":"Gabeau-Lacet D, Engler D, Gupta S, Scangas GA, Betensky RA, Barker FG II, Loeffler JS, Louis DN, Mohapatra G (2009) Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J Neuropathol Exp Neurol 68:1155\u20131165","journal-title":"J Neuropathol Exp Neurol"},{"key":"342_CR68","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cancergencyto.2008.03.015","volume":"184","author":"W Krupp","year":"2008","unstructured":"Krupp W, Holland H, Koschny R, Bauer M, Schober R, Kirsten H, Livrea M, Meixensberger J, Ahnert P (2008) Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics. Cancer Genet Cytogenet 184:87\u201393","journal-title":"Cancer Genet Cytogenet"},{"key":"342_CR69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cancergencyto.2006.10.008","volume":"174","author":"AF Pelz","year":"2007","unstructured":"Pelz AF, Klawunde P, Skalej M, Wieacker P, Kirches E, Schneider T, Mawrin C (2007) Novel chromosomal aberrations in a recurrent malignant meningioma. Cancer Genet Cytogenet 174:48\u201353","journal-title":"Cancer Genet Cytogenet"},{"key":"342_CR70","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-9440(10)61737-3","volume":"159","author":"J Bostrom","year":"2001","unstructured":"Bostrom J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G (2001) Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 159:661\u2013669","journal-title":"Am J Pathol"},{"key":"342_CR71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1750-3639.2002.tb00433.x","volume":"12","author":"A Perry","year":"2002","unstructured":"Perry A, Banerjee R, Lohse CM, Kleinschmidt-DeMasters BK, Scheithauer BW (2002) A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol 12:183\u2013190","journal-title":"Brain Pathol"},{"key":"342_CR72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/FVNU-7UBY-DXE3-77MT","volume":"115","author":"DX Cai","year":"2001","unstructured":"Cai DX, James CD, Scheithauer BW, Couch FJ, Perry A (2001) PS6K amplification characterizes a small subset of anaplastic meningiomas. Am J Clin Pathol 115:213\u2013218","journal-title":"Am J Clin Pathol"},{"key":"342_CR73","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.20201","volume":"56","author":"EI Surace","year":"2004","unstructured":"Surace EI, Lusis E, Haipek CA, Gutmann DH (2004) Functional significance of S6K overexpression in meningioma progression. Ann Neurol 56:295\u2013298","journal-title":"Ann Neurol"},{"key":"342_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2009.08.003","volume":"196","author":"V Martinez-Glez","year":"2010","unstructured":"Martinez-Glez V, Alvarez L, Franco-Hernandez C, Torres-Martin M, de Campos JM, Isla A, Vaquero J, Lassaletta L, Castresana JS, Casartelli C, Rey JA (2010) Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas. Cancer Genet Cytogenet 196:1\u20136","journal-title":"Cancer Genet Cytogenet"},{"key":"342_CR75","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, Cheunsuchon P, Louis DN, Klibanski A (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70:2350\u20132358","journal-title":"Cancer Res"},{"key":"342_CR76","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/modpathol.3800111","volume":"17","author":"VJ Amatya","year":"2004","unstructured":"Amatya VJ, Takeshima Y, Inai K (2004) Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Mod Pathol 17:705\u2013710","journal-title":"Mod Pathol"},{"key":"342_CR77","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ijc.1467","volume":"94","author":"T Joachim","year":"2001","unstructured":"Joachim T, Ram Z, Rappaport ZH, Simon M, Schramm J, Wiestler OD, von Deimling A (2001) Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas. Int J Cancer 94:218\u2013221","journal-title":"Int J Cancer"},{"key":"342_CR78","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","volume":"65","author":"EA Lusis","year":"2005","unstructured":"Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65:7121\u20137126","journal-title":"Cancer Res"},{"key":"342_CR79","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","volume":"36","author":"Y Liu","year":"2005","unstructured":"Liu Y, Pang JC, Dong S, Mao B, Poon WS, Ng HK (2005) Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum Pathol 36:416\u2013425","journal-title":"Hum Pathol"},{"key":"342_CR80","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1158\/0008-5472.CAN-04-3651","volume":"65","author":"PG Buckley","year":"2005","unstructured":"Buckley PG, Jarbo C, Menzel U, Mathiesen T, Scott C, Gregory SG, Langford CF, Dumanski JP (2005) Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. Cancer Res 65:2653\u20132661","journal-title":"Cancer Res"},{"key":"342_CR81","first-page":"341","volume":"25","author":"J Ruiz","year":"2010","unstructured":"Ruiz J, Martinez A, Hernandez S, Zimman H, Ferrer M, Fernandez C, Saez M, Lopez-Asenjo JA, Sanz-Ortega J (2010) Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II. Histol Histopathol 25:341\u2013349","journal-title":"Histol Histopathol"},{"key":"342_CR82","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cancergencyto.2005.02.009","volume":"162","author":"S Piaskowski","year":"2005","unstructured":"Piaskowski S, Rieske P, Szybka M, Wozniak K, Bednarek A, Pluciennik E, Jaskolski D, Sikorska B, Liberski PP (2005) GADD45A and EPB41 as tumor suppressor genes in meningioma pathogenesis. Cancer Genet Cytogenet 162:63\u201367","journal-title":"Cancer Genet Cytogenet"},{"key":"342_CR83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11060-007-9498-9","volume":"87","author":"WK Pfisterer","year":"2008","unstructured":"Pfisterer WK, Coons SW, Aboul-Enein F, Hendricks WP, Scheck AC, Preul MC (2008) Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue. J Neurooncol 87:43\u201350","journal-title":"J Neurooncol"},{"key":"342_CR84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.20733","volume":"114","author":"G Wrobel","year":"2005","unstructured":"Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. IntJ Cancer 114:249\u2013256","journal-title":"IntJ Cancer"},{"key":"342_CR85","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00432-009-0708-z","volume":"136","author":"N Pecina-Slaus","year":"2009","unstructured":"Pecina-Slaus N, Nikuseva Martic T, Deak AJ, Zeljko M, Hrascan R, Tomas D, Musani V (2009) Genetic and protein changes of E-cadherin in meningiomas. J Cancer Res Clin Oncol 136:695\u2013702","journal-title":"J Cancer Res Clin Oncol"},{"key":"342_CR86","doi-asserted-by":"crossref","unstructured":"Zhou K, Wang G, Wang Y, Jin H, Yang S, Liu C (2010) The Potential Involvement of E-cadherin and beta-catenins in Meningioma. PLoS One 5:e11231","DOI":"10.1371\/journal.pone.0011231"},{"key":"342_CR87","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s004280050151","volume":"432","author":"K Schwechheimer","year":"1998","unstructured":"Schwechheimer K, Zhou L, Birchmeier W (1998) E-Cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas. Virchows Arch 432:163\u2013167","journal-title":"Virchows Arch"},{"key":"342_CR88","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.00332-09","volume":"29","author":"O Saydam","year":"2009","unstructured":"Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO (2009) Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway. Mol Cell Biol 29:5923\u20135940","journal-title":"Mol Cell Biol"},{"key":"342_CR89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-007-9500-6","volume":"87","author":"N Pecina-Slaus","year":"2008","unstructured":"Pecina-Slaus N, Nikuseva Martic T, Tomas D, Beros V, Zeljko M, Cupic H (2008) Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol 87:63\u201370","journal-title":"J Neurooncol"},{"key":"342_CR90","first-page":"26","volume":"2010","author":"I Laurendeau","year":"2010","unstructured":"Laurendeau I, Ferrer M, Garrido D, D\u2019Haene N, Ciavarelli P, Basso A, Vidaud M, Bieche I, Salmon I, Szijan I (2010) Gene expression profiling of the Hedgehog signaling pathway in human meningiomas. Mol Med 2010:26","journal-title":"Mol Med"},{"key":"342_CR91","first-page":"2369","volume":"57","author":"J Xie","year":"1997","unstructured":"Xie J, Johnson RL, Zhang X, Bare JW, Waldman FM, Cogen PH, Menon AG, Warren RS, Chen LC, Scott MP, Epstein EH Jr (1997) Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 57:2369\u20132372","journal-title":"Cancer Res"},{"key":"342_CR92","doi-asserted-by":"crossref","unstructured":"Hankins GR, Sasaki T, Lieu AS, Saulle D, Karimi K, Li JZ, Helm GA (2008) Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Neurosurgery 63:771\u2013780; discussion 780\u2013771","DOI":"10.1227\/01.NEU.0000325488.72518.9E"},{"key":"342_CR93","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","volume":"20","author":"Y Lee","year":"2010","unstructured":"Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D, Dong J, Liau L, Becker D, Mischel P, Shams S, Nelson S (2010) Genomic landscape of meningiomas. Brain Pathol 20:751\u2013762","journal-title":"Brain Pathol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0342-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-010-0342-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-010-0342-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T23:45:24Z","timestamp":1711755924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-010-0342-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["342"],"URL":"https:\/\/doi.org\/10.1007\/s11060-010-0342-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}